bioAffinity Technologies Income Statement (2021-2026) | BIAF

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.00M0.00M0.00M921.000.02M0.30M2.21M2.41M2.40M2.35M2.21M1.85M1.27M1.45M1.59M1.35M
Cost of Revenue (Quarter) 146.00146.00175.0087.000.00M0.07M1.66M1.57M1.41M1.44M1.56M1.37M1.02M0.94M0.90M
Gross Profit (Quarter) 0.00M0.00M0.00M834.000.02M0.22M0.55M0.83M0.99M0.91M0.65M0.49M0.25M0.50M0.69M
Operating items
Depreciation & Amortization - Total (Quarter) 800.000.01M0.02M0.02M0.05M0.17M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.02M
Research & Development (Quarter) 0.33M0.13M0.28M0.25M0.32M0.45M0.37M0.34M0.33M0.43M0.39M0.40M0.27M0.39M0.37M0.31M0.33M0.37M0.35M
Selling, General & Administrative (Quarter) 0.16M0.48M0.39M0.41M0.60M1.19M1.15M1.40M2.02M2.21M2.19M2.47M2.36M2.92M2.45M2.21M2.21M3.04M3.24M
Other Operating Expenses (Quarter) 0.03M0.05M0.05M0.03M0.06M-0.02M0.02M0.04M0.19M1.74M1.73M1.57M1.64M1.80M-1.50M1.21M1.15M1.28M-2.69M
Operating Expenses (Quarter) 0.53M0.66M0.73M0.69M0.98M1.63M1.56M1.80M2.59M4.56M4.35M4.49M4.32M5.15M1.37M3.79M3.74M4.73M0.93M
Operating Income (Quarter) -0.53M-0.66M-0.73M-0.68M-0.98M-1.62M-1.56M-1.78M-2.29M-2.34M-1.95M-2.09M-1.97M-2.95M-2.63M-2.52M-2.29M-3.14M-3.62M
EBIT (Quarter) -0.53M-0.66M-0.73M-0.68M-0.98M-1.62M-1.56M-1.78M-2.29M-2.34M-1.95M-2.09M-1.97M-2.95M-2.63M-2.52M-2.29M-3.14M-3.62M
Non-operating items
Interest & Investment Income (Quarter) 19.00400.00276.000.01M0.04M0.04M0.04M0.03M0.01M0.01M0.01M0.00M0.00M542.000.00M0.00M0.02M0.01M
Other Non Operating Income (Quarter) 0.21M0.00M-0.00M0.00M1.000.01M640.002.000.04M513.000.00M
Non Operating Income (Quarter) -1.15M0.04M0.04M0.01M-0.03M-0.01M-0.02M-0.02M-0.02M-0.02M-1.52M-2.76M0.00M-0.01M
Net income details
EBT (Quarter) -1.51M-5.58M-1.47M-0.09M-4.92M-1.67M-1.52M-1.74M-2.29M-2.37M-1.96M-2.10M-2.00M-2.97M-2.65M-4.03M-5.05M-3.13M-3.63M
Tax Provisions (Quarter) 0.00M300.00-1.000.01M0.00M0.00M0.00M0.00M0.01M0.00M0.01M0.03M0.00M0.00M
Profit After Tax (Quarter) -1.51M-5.58M-1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M-3.14M-3.63M
Income from Continuing Operations (Quarter) -1.51M-5.58M-1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M-3.14M-3.63M
Consolidated Net Income (Quarter) -1.51M-5.58M-1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M-3.14M-3.63M
Income towards Parent Company (Quarter) -1.51M-5.58M-1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M-3.14M-3.63M
Net Income towards Common Stockholders (Quarter) -1.51M-5.58M-1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M-3.14M-3.63M
Additional items
EPS (Basic) (Quarter) -0.57-2.08-0.55-0.03-1.170.22-0.18-0.20-0.26-0.26-0.20-0.19-4.84-6.28-4.80-0.17-4.74-1.11-0.81
EPS (Weighted Average and Diluted) (Quarter) -0.03-1.170.22-0.18-0.20-0.26-0.26-0.20-0.19-4.84-6.28-4.80-0.17-4.74-1.11-0.81
Shares Outstanding (Weighted Average) (Quarter) 2.68M0.46M2.68M2.69M4.20M4.50M8.43M4.65M8.70M8.75M8.84M11.39M0.41M0.40M0.54M28.19M1.35M1.35M4.49M
Shares Outstanding (Diluted Average) (Quarter) 2.69M3.19M4.50M8.43M8.48M8.70M8.75M9.92M10.66M0.37M0.40M0.54M24.02M1.07M1.72M4.49M
EBITDA (Quarter) -0.53M-0.66M-0.73M-0.68M-0.98M-1.62M-1.54M-1.76M-2.25M-2.18M-1.91M-2.05M-1.93M-2.90M-2.58M-2.47M-2.25M-3.10M-3.59M
Interest Expenses (Quarter) 0.14M0.64M0.40M0.90M0.09M0.00M0.00M0.01M0.01M0.02M0.02M0.01M8.000.02M0.48M0.00M0.47M0.01M
Tax Rate (Quarter) -0.15%-0.01%0.00%-0.78%-0.26%-0.10%-0.10%-0.19%-0.26%-0.13%-0.33%-0.72%-0.06%-0.10%